Back to MW MARSHALL WACE, LLP

ENTAENTA
26 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ENANTA PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 131,995 shares of ENTA (ENANTA PHARMACEUTICALS INC), worth $1.9M as of 2026-Q2. The position was decreased (-37.2% shares). ENTA represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$1.9M

Current Shares

131,995

Total Value Change

-$8.8M

Total Shares Change

-19,896

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
131,995
-37.2%
$1.9M0.0%$14.58
0
2026-Q1
Decreased
210,070
-45.5%
$2.7M0.0%$14.72
0
2025-Q4
Increased
385,276
+39.9%
$6.1M0.0%$15.90
36
2025-Q3
Decreased
275,389
-67.9%
$3.3M0.0%$15.16
0
2025-Q2
Increased
857,412
+0.8%
$6.5M0.0%$7.50
27
2025-Q1
Decreased
850,890
-8.5%
$4.7M0.0%$5.71
0
2024-Q4
Increased
930,087
+9.3%
$5.3M0.0%$5.85
30
2024-Q3
Decreased
850,890
-8.3%
$8.8M0.0%$10.05
0
2024-Q2
Decreased
928,363
-2.4%
$12M0.0%$12.97
0
2024-Q1
New
951,062
-
$16.6M0.0%$17.46
39
2023-Q4
Exited
0
-100.0%
$00.0%$9.41
0
2023-Q3
New
74,810
-
$835,6270.0%$11.17
34
2022-Q3
Exited
0
-100.0%
$00.0%$52.42
0
2022-Q2
New
50,160
-
$2.4M0.0%$46.91
36
2022-Q1
Exited
0
-100.0%
$00.0%$69.22
0
2021-Q4
New
9,670
-
$723,0000.0%$74.57
34
2021-Q1
Exited
0
-100.0%
$00.0%$48.07
0
2020-Q4
Decreased
9,952
-71.5%
$419,0000.0%$41.54
0
2020-Q3
Decreased
34,934
-73.5%
$1.6M0.0%$44.83
0
2020-Q2
Decreased
131,824
-47.7%
$6.6M0.0%$49.04
0
2020-Q1
Increased
251,961
+39.2%
$13M0.1%$50.69
44
2019-Q4
Increased
181,055
+5.0%
$11.2M0.1%$61.54
29
2019-Q3
Increased
172,373
+12.1%
$10.4M0.1%$60.28
31
2019-Q2
Decreased
153,786
-46.8%
$13M0.1%$84.38
0
2019-Q1
Increased
288,906
+90.2%
$27.6M0.1%$95.52
54
2018-Q4
New
151,891
-
$10.8M0.1%$70.13
46

Other major holders of ENTA: BNP PARIBAS FINANCIAL MARKETS, FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used